284 related articles for article (PubMed ID: 37085010)
41. Targeting the microbiota-mitochondria crosstalk in neurodegeneration with senotherapeutics.
Homolak J
Adv Protein Chem Struct Biol; 2023; 136():339-383. PubMed ID: 37437983
[TBL] [Abstract][Full Text] [Related]
42. The effect of aged microglia on synaptic impairment and its relevance in neurodegenerative diseases.
Triviño JJ; von Bernhardi R
Neurochem Int; 2021 Mar; 144():104982. PubMed ID: 33556444
[TBL] [Abstract][Full Text] [Related]
43. Emerging senolytic agents derived from natural products.
Li W; Qin L; Feng R; Hu G; Sun H; He Y; Zhang R
Mech Ageing Dev; 2019 Jul; 181():1-6. PubMed ID: 31077707
[TBL] [Abstract][Full Text] [Related]
44. Targeting Cellular Senescence with Senotherapeutics: Development of New Approaches for Skin Care.
Thompson EL; Pitcher LE; Niedernhofer LJ; Robbins PD
Plast Reconstr Surg; 2022 Oct; 150():12S-19S. PubMed ID: 36170431
[TBL] [Abstract][Full Text] [Related]
45. Recent advances in the discovery of senolytics.
Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
Mech Ageing Dev; 2021 Dec; 200():111587. PubMed ID: 34656616
[TBL] [Abstract][Full Text] [Related]
46. Cellular Senescence as a Therapeutic Target for Age-Related Diseases: A Review.
Amaya-Montoya M; Pérez-Londoño A; Guatibonza-García V; Vargas-Villanueva A; Mendivil CO
Adv Ther; 2020 Apr; 37(4):1407-1424. PubMed ID: 32185730
[TBL] [Abstract][Full Text] [Related]
47. Ageing, Cellular Senescence and Neurodegenerative Disease.
Kritsilis M; V Rizou S; Koutsoudaki PN; Evangelou K; Gorgoulis VG; Papadopoulos D
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30261683
[TBL] [Abstract][Full Text] [Related]
48. Aging, Senescence, and Dementia.
Behfar Q; Ramirez Zuniga A; Martino-Adami PV
J Prev Alzheimers Dis; 2022; 9(3):523-531. PubMed ID: 35841253
[TBL] [Abstract][Full Text] [Related]
49. Cellular senescence: a key therapeutic target in aging and diseases.
Zhang L; Pitcher LE; Yousefzadeh MJ; Niedernhofer LJ; Robbins PD; Zhu Y
J Clin Invest; 2022 Aug; 132(15):. PubMed ID: 35912854
[TBL] [Abstract][Full Text] [Related]
50. Cellular senescence in neuroinflammatory disease: new therapies for old cells?
Nelke C; Schroeter CB; Pawlitzki M; Meuth SG; Ruck T
Trends Mol Med; 2022 Oct; 28(10):850-863. PubMed ID: 35965205
[TBL] [Abstract][Full Text] [Related]
51. The costs and benefits of senotherapeutics for human health.
Raffaele M; Vinciguerra M
Lancet Healthy Longev; 2022 Jan; 3(1):e67-e77. PubMed ID: 36098323
[TBL] [Abstract][Full Text] [Related]
52. Senotherapeutic Drugs: A New Avenue for Skincare?
Lee BP; Harries LW
Plast Reconstr Surg; 2021 Dec; 148(6S):21S-26S. PubMed ID: 34847094
[TBL] [Abstract][Full Text] [Related]
53. Cellular Senescence: A Translational Perspective.
Kirkland JL; Tchkonia T
EBioMedicine; 2017 Jul; 21():21-28. PubMed ID: 28416161
[TBL] [Abstract][Full Text] [Related]
54. Biomolecular Evaluation of Piceatannol's Effects in Counteracting the Senescence of Mesenchymal Stromal Cells: A New Candidate for Senotherapeutics?
Alessio N; Squillaro T; Lettiero I; Galano G; De Rosa R; Peluso G; Galderisi U; Di Bernardo G
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769049
[TBL] [Abstract][Full Text] [Related]
55. Therapeutic opportunities for senolysis in cardiovascular disease.
Sweeney M; Cook SA; Gil J
FEBS J; 2023 Mar; 290(5):1235-1255. PubMed ID: 35015342
[TBL] [Abstract][Full Text] [Related]
56. Lessons from inducible pluripotent stem cell models on neuronal senescence in aging and neurodegeneration.
de Luzy IR; Lee MK; Mobley WC; Studer L
Nat Aging; 2024 Mar; 4(3):309-318. PubMed ID: 38429379
[TBL] [Abstract][Full Text] [Related]
57. Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span.
Robbins PD; Jurk D; Khosla S; Kirkland JL; LeBrasseur NK; Miller JD; Passos JF; Pignolo RJ; Tchkonia T; Niedernhofer LJ
Annu Rev Pharmacol Toxicol; 2021 Jan; 61():779-803. PubMed ID: 32997601
[TBL] [Abstract][Full Text] [Related]
58. Cellular Senescence in Human Skin Aging: Leveraging Senotherapeutics.
Wyles SP; Carruthers JD; Dashti P; Yu G; Yap JQ; Gingery A; Tchkonia T; Kirkland J
Gerontology; 2024; 70(1):7-14. PubMed ID: 37879300
[TBL] [Abstract][Full Text] [Related]
59. Targeting Cell Senescence for the Treatment of Age-Related Bone Loss.
Pignolo RJ; Samsonraj RM; Law SF; Wang H; Chandra A
Curr Osteoporos Rep; 2019 Apr; 17(2):70-85. PubMed ID: 30806947
[TBL] [Abstract][Full Text] [Related]
60. [Cellular senescence as a common denominator in age-related diseases].
Maciel-Barón LÁ; Pérez VI; Torres C; González-Puertos VY; Konigsberg M; López-Diazguerrero NE
Rev Med Inst Mex Seguro Soc; 2017; 55(4):490-497. PubMed ID: 28591504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
